40 related articles for article (PubMed ID: 37551766)
1. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
4. Muscone restores anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR/Integrin β1/FAK signaling pathway.
Zou Y; Xu L; Wang W; Zhu X; Lin J; Li H; Chen J; Xu W; Gao H; Wu X; Yin Z; Wang Q
Phytomedicine; 2024 Jul; 129():155714. PubMed ID: 38723526
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.
Cai T; Liu Y; Xiao J
Cancer Med; 2018 Apr; 7(4):1404-1415. PubMed ID: 29479863
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for hypoxia
Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
[TBL] [Abstract][Full Text] [Related]
7. Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the
Wang D; Wang Z; Dai X; Zhang L; Li M
Cancer Biother Radiopharm; 2024 Mar; 39(2):125-132. PubMed ID: 33471569
[No Abstract] [Full Text] [Related]
8. RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway.
Sun Q; Xu J; Yuan F; Liu Y; Chen Q; Guo L; Dong H; Liu B
Cancer Biol Ther; 2024 Dec; 25(1):2321770. PubMed ID: 38444223
[TBL] [Abstract][Full Text] [Related]
9. Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
Cui X; Zhao J; Li G; Yang C; Yang S; Zhan Q; Zhou J; Wang Y; Xiao M; Hong B; Yi K; Tong F; Tan Y; Wang H; Wang Q; Jiang T; Fang C; Kang C
Cancer Commun (Lond); 2023 Dec; 43(12):1326-1353. PubMed ID: 37920878
[TBL] [Abstract][Full Text] [Related]
10. Daurisoline suppress glioma progression by inhibiting autophagy through PI3K/AKT/mTOR pathway and increases TMZ sensitivity.
Yin HT; Hui-Lu ; Yang JH; Li Q; Li M; Zhao QQ; Wen ZP
Biochem Pharmacol; 2024 May; 223():116113. PubMed ID: 38460907
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Low-Frequency Radiation Changes the Expression of Nestin, VEGF, BCRP and Apoptosis Markers During Glioma Treatment Strategy: An
Amirinejad M; Eftekhar-Vaghefi SH; Nematollahi Mahani SN; Salari M; Yahyapour R; Ahmadi-Zeidabadi M
Curr Radiopharm; 2024; 17(1):55-67. PubMed ID: 38817005
[TBL] [Abstract][Full Text] [Related]
13. Regulation and molecular mechanism of adiponectin on the proliferation, apoptosis, autophagy, and chemosensitivity of LN18 Glioma cell line.
Sun P; Huo K; Liu F; Cheng Y; Chen C; Han J; Yu J
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):178-186. PubMed ID: 38836664
[TBL] [Abstract][Full Text] [Related]
14. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
Towner RA; Smith N; Saunders D; Brown CA; Cai X; Ziegler J; Mallory S; Dozmorov MG; Coutinho De Souza P; Wiley G; Kim K; Kang S; Kong DS; Kim YT; Fung KM; Wren JD; Battiste J
Transl Oncol; 2019 Feb; 12(2):320-335. PubMed ID: 30468988
[TBL] [Abstract][Full Text] [Related]
15. BMSC derived EVs inhibit colorectal Cancer progression by transporting MAGI2-AS3 or something similar.
Ma T; Wang M; Wang S; Hu H; Zhang X; Wang H; Wang G; Jin Y
Cell Signal; 2024 May; ():111235. PubMed ID: 38806109
[TBL] [Abstract][Full Text] [Related]
16. A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.
Lin WH; Feathers RW; Cooper LM; Lewis-Tuffin LJ; Chen J; Sarkaria JN; Anastasiadis PZ
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427593
[TBL] [Abstract][Full Text] [Related]
17. ZNF384 transcriptionally activated MGST1 to confer TMZ resistance of glioma cells by negatively regulating ferroptosis.
Yan T; Hu P; Lv S; Ye M; Wu M; Fang H; Xiao B
Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38824270
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2.
Li G; Xiong Z; Li Y; Yan C; Cheng Y; Wang Y; Li J; Dai Z; Zhang D; Du W; Men C; Shi C
Discov Oncol; 2024 Apr; 15(1):110. PubMed ID: 38598023
[TBL] [Abstract][Full Text] [Related]
19. The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.
Pessina S; Cantini G; Kapetis D; Cazzato E; Di Ianni N; Finocchiaro G; Pellegatta S
Oncoimmunology; 2016 May; 5(5):e1108513. PubMed ID: 27467914
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of necroptosis related genes and lncRNAs in patients with pituitary neuroendocrine tumors.
Askari A; Darabi MR; Eslami S; Jamali E; Sharifi G; Ghafouri-Fard S; Dilmaghani NA
Pathol Res Pract; 2024 Jun; 258():155332. PubMed ID: 38696856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
